Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial
収録刊行物
-
- The Lancet Oncology
-
The Lancet Oncology 14 (10), 953-961, 2013-09
Elsevier BV